TABLE 2

Arcaine does not affect the release of [3H]NE evoked by NMDA/glycine in absence or in presence of Tat from human and rat nerve endings

Human and rat synaptosomes were superfused with Mg2+-free medium and exposed, respectively, to 1 mM NMDA + 3 μM glycine (human synaptosomes) or to 100 μM NMDA + 1 μM glycine (rat synaptosomes). When indicated, 1 nM Tat was added together with agonists, whereas arcaine was present from 8 min before agonists. Results are expressed as percentage increase over basal release; data are means ± S.E.M. of five (human) and three to six (rat) experiments run in triplicate. Arcaine did not affect on its own the spontaneous release of tritium (not shown).



Human

Rat

NMDA + Glycine
NMDA + Glycine + Tat
NMDA + Glycine
NMDA + Glycine + Tat
Control 21.22 ± 3.05 72.02 ± 11.78a 56.09 ± 1.31 89.74 ± 8.50a
+Arcaine (30 μM)
18.46 ± 3.46
75.83 ± 12.41a
55.28 ± 3.52
97.45 ± 11.20a
  • a p < 0.05 vs. respective control [human, F(3,16) = 8.29; rat, F(3,23) = 9.71].